Philip B. Cox

1.9k total citations · 2 hit papers
22 papers, 1.2k citations indexed

About

Philip B. Cox is a scholar working on Organic Chemistry, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Philip B. Cox has authored 22 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 11 papers in Molecular Biology and 6 papers in Computational Theory and Mathematics. Recurrent topics in Philip B. Cox's work include Computational Drug Discovery Methods (6 papers), Chemical Synthesis and Analysis (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Philip B. Cox is often cited by papers focused on Computational Drug Discovery Methods (6 papers), Chemical Synthesis and Analysis (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Philip B. Cox collaborates with scholars based in United States and United Kingdom. Philip B. Cox's co-authors include Jón T. Njardarson, David A. DeGoey, Hui-Ju Chen, Michael Wendt, Kevin A. Scott, Philip Garner, Rishi Gupta, Paul Erdman, Stephen J. Klippenstein and Stanley M. Roberts and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Philip B. Cox

21 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)

2024 357 citations Philip B. Cox, Jón T. Njardarson et al. Journal of Medicinal Chemistry profile →
Phenols in Pharmaceuticals: Analysis of a Recurring Motif

2022 133 citations Kevin A. Scott, Philip B. Cox et al. Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip B. Cox United States	16	709	468	206	105	103	22	1.2k
Matthias Urmann Germany	16	390 0.6×	322 0.7×	141 0.7×	76 0.7×	117 1.1×	23	940
Jean‐Marc Plancher Switzerland	19	871 1.2×	456 1.0×	173 0.8×	208 2.0×	257 2.5×	27	1.5k
Sandhya Bawa India	19	1.6k 2.3×	543 1.2×	144 0.7×	59 0.6×	106 1.0×	51	2.0k
Harry Finch United Kingdom	17	563 0.8×	286 0.6×	95 0.5×	71 0.7×	86 0.8×	62	982
Srikanth Venkatraman United States	24	1.0k 1.4×	410 0.9×	82 0.4×	36 0.3×	107 1.0×	50	1.4k
Juan C. Alvarez United States	11	395 0.6×	477 1.0×	317 1.5×	40 0.4×	85 0.8×	14	1.1k
Zhaoqiang Chen China	19	473 0.7×	337 0.7×	90 0.4×	81 0.8×	143 1.4×	34	1.1k
Zdenko Časar Slovenia	20	653 0.9×	349 0.7×	74 0.4×	75 0.7×	143 1.4×	70	1.2k
Ralph P. Robinson United States	19	1.3k 1.8×	575 1.2×	61 0.3×	163 1.6×	101 1.0×	42	1.7k
Akranth Marella India	13	1.0k 1.5×	310 0.7×	133 0.6×	36 0.3×	80 0.8×	21	1.3k

Countries citing papers authored by Philip B. Cox

Since Specialization

Citations

This map shows the geographic impact of Philip B. Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip B. Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip B. Cox more than expected).

Fields of papers citing papers by Philip B. Cox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip B. Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip B. Cox. The network helps show where Philip B. Cox may publish in the future.

Co-authorship network of co-authors of Philip B. Cox

This figure shows the co-authorship network connecting the top 25 collaborators of Philip B. Cox. A scholar is included among the top collaborators of Philip B. Cox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip B. Cox. Philip B. Cox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Price, Edward, Richard S. Hong, J. Cory Kalvass, et al.. (2025). Explainable Machine Learning for ETR and Drug Chameleonicity. Journal of Medicinal Chemistry. 68(15). 15636–15648.

Cox, Philip B., et al.. (2024). An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023). Journal of Medicinal Chemistry. 67(14). 11622–11655. 357 indexed citations breakdown →

Price, Edward, Alexey Rivkin, Gary J. Jenkins, et al.. (2024). Beyond Rule of Five and PROTACs in Modern Drug Discovery: Polarity Reducers, Chameleonicity, and the Evolving Physicochemical Landscape. Journal of Medicinal Chemistry. 67(7). 5683–5698. 41 indexed citations

Scott, Kevin A., Philip B. Cox, & Jón T. Njardarson. (2022). Phenols in Pharmaceuticals: Analysis of a Recurring Motif. Journal of Medicinal Chemistry. 65(10). 7044–7072. 133 indexed citations breakdown →

Cox, Philip B. & Rishi Gupta. (2022). Contemporary Computational Applications and Tools in Drug Discovery. ACS Medicinal Chemistry Letters. 13(7). 1016–1029. 42 indexed citations

Scott, Kevin A., et al.. (2020). A Structural Analysis of the FDA Green Book-Approved Veterinary Drugs and Roles in Human Medicine. Journal of Medicinal Chemistry. 63(24). 15449–15482. 34 indexed citations

Cox, Brian J., et al.. (2020). Escaping from Flatland: Substituted Bridged Pyrrolidine Fragments with Inherent Three-Dimensional Character. ACS Medicinal Chemistry Letters. 11(6). 1185–1190. 58 indexed citations

Wang, Youli, Todd Merchen, Philip B. Cox, et al.. (2019). Differential Expression of Prostaglandin E2 Receptors in Porcine Kidney Transplants. Transplantation Proceedings. 51(6). 2124–2131. 1 indexed citations

Lee, Melissa, et al.. (2019). Access to 3D Alicyclic Amine-Containing Fragments through Transannular C–H Arylation. Synlett. 30(4). 417–422. 16 indexed citations

10.

Garner, Philip, et al.. (2019). Design and Synthesis of Pyrrolidine-based Fragments That Sample Three-dimensional Molecular Space. ACS Medicinal Chemistry Letters. 10(5). 811–815. 30 indexed citations

11.

DeGoey, David A., Hui-Ju Chen, Philip B. Cox, & Michael Wendt. (2017). Beyond the Rule of 5: Lessons Learned from AbbVie’s Drugs and Compound Collection. Journal of Medicinal Chemistry. 61(7). 2636–2651. 270 indexed citations

12.

Cox, Philip B., Robert J. Gregg, & Anil Vasudevan. (2012). Abbott Physicochemical Tiering (APT)—A unified approach to HTS triage. Bioorganic & Medicinal Chemistry. 20(14). 4564–4573. 25 indexed citations

13.

Mochalkin, Igor, J. Richard Miller, Lakshmi Narasimhan, et al.. (2009). Discovery of Antibacterial Biotin Carboxylase Inhibitors by Virtual Screening and Fragment-Based Approaches. ACS Chemical Biology. 4(6). 473–483. 75 indexed citations

14.

Cox, Philip B., et al.. (2001). The solid phase synthesis of unsymmetrical phosphinic acids. Tetrahedron Letters. 42(1). 125–128. 4 indexed citations

15.

Baxter, Anthony D., et al.. (2000). 4,6-Dichloro-5-nitropyrimidine: a versatile building block for the solid phase synthesis of dihydropteridinones. Tetrahedron Letters. 41(42). 8177–8181. 11 indexed citations

16.

Garner, Philip, et al.. (1997). Use of Silicon-Based Tethers to Control Diastereofacial Selectivity in Azomethine Ylide Cycloadditions¹. The Journal of Organic Chemistry. 62(3). 493–498. 30 indexed citations

17.

Garner, Philip, Philip B. Cox, & Stephen J. Klippenstein. (1995). Auxiliary Induced .rho.-Stereocontrol in Acetaloxyalkyl Radical Addition Reactions. Journal of the American Chemical Society. 117(14). 4183–4184. 18 indexed citations

18.

Garner, Philip, Philip B. Cox, Stephen J. Klippenstein, Wiley J. Youngs, & David B. McConville. (1994). Tether-Mediated Stereocontrol in Intramolecular Azomethine Ylide Cycloadditions. The Journal of Organic Chemistry. 59(22). 6510–6511. 18 indexed citations

19.

Cotterill, Ian C., Philip B. Cox, Alex F. Drake, et al.. (1991). Enzyme-catalysed hydrolyses of some meso-diesters. Journal of the Chemical Society Perkin Transactions 1. 3071–3071. 9 indexed citations

20.

Chan, Cecil, Philip B. Cox, & Stanley M. Roberts. (1988). Convergent stereocontrolled synthesis of 13-hydroxy-9Z, 11E-octadecadienoic acid (13-HODE). Journal of the Chemical Society Chemical Communications. 971–971. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact